Virtu Financial LLC Chembio Diagnostics, Inc. Transaction History

Virtu Financial LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.25 - $0.45 $15,661 - $28,190	62,646 Added 77.71%	143,265 $63,000
Q4 2022 Feb 15, 2023	BUY	$0.2 - $0.33 $16,123 - $26,604	80,619 New	80,619 $18,000
Q2 2022 Aug 09, 2022	SELL	$0.45 - $0.8 $16,684 - $29,661	-37,077 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$0.66 - $1.23 $54,226 - $101,058	-82,161 Reduced 68.91%	37,077 $30,000
Q4 2021 Feb 17, 2022	BUY	$1.09 - $2.55 $108,547 - $253,941	99,585 Added 506.72%	119,238 $136,000
Q3 2021 Nov 12, 2021	BUY	$2.06 - $5.34 $40,485 - $104,947	19,653 New	19,653 $49,000
Q1 2021 May 19, 2021	SELL	$3.4 - $7.97 $210,803 - $494,147	-62,001 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$4.11 - $7.51 $254,824 - $465,627	62,001 New	62,001 $295,000
Q3 2020 Dec 11, 2020	SELL	$3.28 - $5.93 $272,161 - $492,047	-82,976 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$3.18 - $15.54 $263,863 - $1.29 Million	82,976 New	82,976 $270,000
Q1 2018 May 14, 2018	SELL	$7.05 - $9.0 $78,487 - $100,197	-11,133 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$5.95 - $8.35 $66,241 - $92,960	11,133	11,133 $91,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.